Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cost of Goods | 50 | N/A | N/A | N/A | N/A |
| Gross Profit | -50 | N/A | N/A | N/A | N/A |
| Operating Expenses | 5,316 | 4,737 | 8,304 | 13,880 | 6,296 |
| Operating Income | -5,316 | -4,737 | -8,304 | -13,880 | -6,296 |
| Interest Expense | -1 | 0 | 0 | 0 | 0 |
| Other Income | -96 | 287 | 993 | 10,482 | -3,079 |
| Pre-tax Income | -5,411 | -4,450 | -7,311 | -3,398 | -9,375 |
| Income Tax | -5 | 40 | 5 | N/A | 0 |
| Net Income Continuous | -5,406 | -4,490 | -7,316 | -3,398 | -9,375 |
| Net Income | $-5,416 | $-4,490 | $-7,316 | $-3,398 | $-9,375 |
| EPS Basic Total Ops | -15.89 | -13.64 | -37.33 | -17.39 | -52.47 |
| EPS Basic Continuous Ops | -15.81 | -13.73 | -37.30 | -17.33 | -52.43 |
| EPS Diluted Total Ops | -15.89 | -13.64 | -37.33 | -17.39 | -52.47 |
| EPS Diluted Continuous Ops | -15.81 | -13.73 | -37.30 | -17.33 | -52.43 |
| EBITDA(a) | $-5,254 | $-4,651 | $-8,183 | $-13,728 | $-6,158 |